Labcorp Holdings Inc (LH) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Labcorp Holdings Inc   (NYSE: LH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Labcorp Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Labcorp Holdings Inc's ROI in the second quarter of 2026?
Labcorp Holdings Inc achieved a return on average invested assets (ROI) of 6.27 % in its second quarter of 2026, which is below Labcorp Holdings Inc's average return on investment, which stands at 8.49%.

ROI has improved compared to 5.99% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 132 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1298 to 1389.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 4.78 % 7.79 % 11.9 % 14.15 % 15.98 %
Y / Y Net Income Change TTM 31.26 % 28.82 % 69.18 % 128.25 % 271.84 %
Investment (TTM) in Millions 16,391 16,429 15,552 15,616 15,326
Return On Investment (TTM) 6.27 % 5.99 % 5.66 % 5.57 % 5.01 %
LH's Overall Ranking # 1389 # 1298 # 882 # 1174 # 956
Seq. Investment Change TTM 1.69 % 1.46 % 0.84 % 0.71 % 4.61 %
Seq. Net Income Change TTM 6.45 % 7.41 % 2.49 % 12.02 % 4.47 %
Net Income (TTM) in Millions 1,004 943 878 856 765

LH Company Profile >> Back to LH Roi Comparisons >> See Annual LH Return On Investment



Return On Investment LH's Ranking
Within: No.
Industry # 5
Sector # 133
Overall # 1389

Return On Investment Statistics
High Average Low
17.21 %
8.49 %
-1.41 %
(Sep. 30, 2007)  







Financial Statements
Labcorp Holdings Inc's II. Quarter Investments $ 16,391 Millions LH's Balance sheet
Labcorp Holdings Inc's II. Quarter Income $ 299 Millions Quarterly LH's Income Statement
LH's Income by Division See LH's Income by Division


LH Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 15,552 15,035 13,484 17,058 16,973
Y / Y Investment Growth 3.44 % 11.5 % -20.95 % 0.5 % 10.42 %
Net Income in Millions 878 747 419 1,281 1,557
Y / Y Net Income Growth 17.48 % 78.22 % -67.27 % -17.75 % 88.75 %
Annual Return On Investment 5.64 % 4.97 % 3.11 % 7.51 % 9.17 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 5.64 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LH's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LH's Competitors
Subscribers only: Roi for Labcorp Holdings Inc's Suppliers
Subscribers only: Return On Investment for LH's Customers

Other Ratios
LH's Roa LH's Inventory Turnover Ratio LH's Growth Rates LH's Dividend Statistics
LH's Profitability Ratios LH's Asset Turnover Ratio LH's Dividend Growth
LH's Roe LH's Valuation Ratios LH's Financial Strength Ratios LH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %

Date modified: 2026-09-12T18:38:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.